AMPH

Amphastar Pharmaceuticals, Inc.

26.62

USD

+0.81

+3.14%

Oct 09, 15:59 UTC -4

Closed

After-Market

26.64

+0.02

+0.06%

AMPH Earnings Reports

Positive Surprise Ratio

AMPH beat 33 of 43 last estimates.

77%

Next Report

Date of Next Report

Nov 04, 2026

Estimate for Q3 26 (Revenue/ EPS)

$201.81M

$0.88

Implied change from Q2 26 (Revenue/ EPS)

+9.74%

-3.30%

Implied change from Q3 25 (Revenue/ EPS)

+5.20%

-5.38%

Amphastar Pharmaceuticals, Inc. earnings per share and revenue

On Aug 06, 2026, AMPH reported earnings of 0.91 USD per share (EPS) for Q2 26, beating the estimate of 0.63 USD, resulting in a 43.87% surprise. Revenue reached 183.90 million, compared to an expected 185.70 million, with a -0.97% difference. The market reacted with a +4.90% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 5 analysts forecast an EPS of 0.88 USD, with revenue projected to reach 201.81 million USD, implying an decrease of -3.30% EPS, and increase of 9.74% in Revenue from the last quarter.

FAQ

What were Amphastar Pharmaceuticals, Inc.'s earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Amphastar Pharmaceuticals, Inc. reported EPS of $0.91, beating estimates by 43.87%, and revenue of $183.90M, -0.97% below expectations.

How did the market react to Amphastar Pharmaceuticals, Inc.'s Q2 2026 earnings?

The stock price moved up 4.9%, changed from $19.81 before the earnings release to $20.78 the day after.

When is Amphastar Pharmaceuticals, Inc. expected to report next?

The next earning report is scheduled for Nov 04, 2026.

What are the forecasts for Amphastar Pharmaceuticals, Inc.'s next earnings report?

Based on 5 analysts, Amphastar Pharmaceuticals, Inc. is expected to report EPS of $0.88 and revenue of $201.81M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.